JP2021531825A5 - - Google Patents

Info

Publication number
JP2021531825A5
JP2021531825A5 JP2021524131A JP2021524131A JP2021531825A5 JP 2021531825 A5 JP2021531825 A5 JP 2021531825A5 JP 2021524131 A JP2021524131 A JP 2021524131A JP 2021524131 A JP2021524131 A JP 2021524131A JP 2021531825 A5 JP2021531825 A5 JP 2021531825A5
Authority
JP
Japan
Prior art keywords
antibody
folr1
linker
cdr1
cdr2
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021524131A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021531825A (ja
JP7623939B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2019/000873 external-priority patent/WO2020016661A2/en
Publication of JP2021531825A publication Critical patent/JP2021531825A/ja
Publication of JP2021531825A5 publication Critical patent/JP2021531825A5/ja
Priority to JP2024056137A priority Critical patent/JP2024119785A/ja
Application granted granted Critical
Publication of JP7623939B2 publication Critical patent/JP7623939B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021524131A 2018-07-09 2019-06-26 葉酸受容体アルファに特異的な抗体 Active JP7623939B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024056137A JP2024119785A (ja) 2018-07-09 2024-03-29 葉酸受容体アルファに特異的な抗体

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862695535P 2018-07-09 2018-07-09
US62/695,535 2018-07-09
PCT/IB2019/000873 WO2020016661A2 (en) 2018-07-09 2019-06-26 Antibodies specific to folate receptor alpha

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024056137A Division JP2024119785A (ja) 2018-07-09 2024-03-29 葉酸受容体アルファに特異的な抗体

Publications (3)

Publication Number Publication Date
JP2021531825A JP2021531825A (ja) 2021-11-25
JP2021531825A5 true JP2021531825A5 (cg-RX-API-DMAC7.html) 2022-07-01
JP7623939B2 JP7623939B2 (ja) 2025-01-29

Family

ID=69165230

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021524131A Active JP7623939B2 (ja) 2018-07-09 2019-06-26 葉酸受容体アルファに特異的な抗体
JP2024056137A Pending JP2024119785A (ja) 2018-07-09 2024-03-29 葉酸受容体アルファに特異的な抗体

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024056137A Pending JP2024119785A (ja) 2018-07-09 2024-03-29 葉酸受容体アルファに特異的な抗体

Country Status (7)

Country Link
US (1) US12378310B2 (cg-RX-API-DMAC7.html)
EP (1) EP3821006A4 (cg-RX-API-DMAC7.html)
JP (2) JP7623939B2 (cg-RX-API-DMAC7.html)
CN (2) CN112955548B (cg-RX-API-DMAC7.html)
AU (1) AU2019304174B2 (cg-RX-API-DMAC7.html)
TW (1) TWI865456B (cg-RX-API-DMAC7.html)
WO (1) WO2020016661A2 (cg-RX-API-DMAC7.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116348485A (zh) 2020-07-17 2023-06-27 英研生物(英国)有限公司 提供用于过继性细胞疗法的靶向共刺激的受体
KR20240017024A (ko) * 2021-06-04 2024-02-06 이뮤노젠 아이엔씨 가용성 fr-알파를 이용한 환자의 암 치료
TW202306997A (zh) 2021-06-16 2023-02-16 英商英斯特生物科技有限公司 用於在過繼細胞療法中提供標靶共刺激之受體
EP4370213A4 (en) 2021-07-16 2025-06-04 Instil Bio (Uk) Limited Chimeric molecules for targeted costimulation for adoptive cell therapy
TW202400247A (zh) * 2022-05-10 2024-01-01 美商索倫多醫療公司 包含抗folr1抗體之抗體藥物結合物
US12649790B2 (en) 2023-07-03 2026-06-09 Medicovestor, Inc. Proteins that bind SP17 including fully-human anti-SP17 antibodies
US12624097B2 (en) 2023-07-03 2026-05-12 Medicovestor, Inc. Nucleic acids, vectors, and cells that encode anti-Sp17 antibodies and other Sp17 binding proteins
WO2025087935A1 (en) * 2023-10-26 2025-05-01 Miltenyi Biotec B.V. & Co. KG Chimeric antigen receptor specific for folate receptor 1
US12600795B2 (en) 2023-12-26 2026-04-14 Medicovestor, Inc. Oligomeric IgG for immunotherapeutics and diagnostics
US12673991B2 (en) 2023-12-26 2026-07-07 Medicovestor, Inc. Methods of crosslinking IgG
US12121587B1 (en) 2023-12-26 2024-10-22 Medicovestor, Inc. Dimeric antibodies
CN117700557B (zh) * 2024-02-05 2024-04-30 卡秋(江苏)生物科技有限公司 一种特异性结合叶酸受体α的抗体或抗原结合片段
WO2025195447A1 (zh) * 2024-03-22 2025-09-25 北京桦冠生物技术有限公司 结合folr1蛋白的抗体、抗体药物偶联物及其用途
US20260001950A1 (en) * 2024-07-01 2026-01-01 Medicovestor, Inc. Methods of enhancing efficacy of immunoconjugates using paired human antibodies targeted at non-overlapping b-cell epitopes on the same antigen

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0905972D0 (en) * 2009-04-06 2009-05-20 Medical Res Council Antibodies against IL-17BR
WO2011016238A1 (en) * 2009-08-06 2011-02-10 Immunas Pharma, Inc. Antibodies that specifically bind to a beta oligomers and use thereof
CN105777907B (zh) * 2010-02-24 2020-03-17 伊缪诺金公司 叶酸受体1抗体与免疫缀合物以及其用途
JP2014509841A (ja) 2011-01-18 2014-04-24 ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア 癌を治療するための組成物および方法
CN107011439B (zh) * 2011-07-15 2020-11-10 卫材R&D管理有限公司 抗叶酸受体α抗体及其应用
CN104884617B (zh) * 2012-12-07 2019-02-19 协和发酵麒麟株式会社 抗folr1抗体
US9522196B2 (en) * 2012-12-25 2016-12-20 Kagoshima University Antibody recognizing folate receptors α and β
JP6463744B2 (ja) * 2013-10-08 2019-02-06 イミュノジェン, インコーポレイテッド 抗folr1免疫抱合体投薬レジメン
CN122399016A (zh) * 2014-03-15 2026-07-17 诺华股份有限公司 使用嵌合抗原受体治疗癌症
US20150297744A1 (en) * 2014-03-28 2015-10-22 Immunogen, Inc. Anti-FOLR1 Immunoconjugate Dosing Regimens
KR20170020868A (ko) * 2014-06-20 2017-02-24 바이오얼라이언스 씨.브이. 항-폴레이트 수용체 알파 (fra) 항체-약물 컨쥬게이트 및 그것의 사용 방법
DK3186284T3 (da) * 2014-08-28 2022-05-09 Bioatla Inc Betinget aktive kimæriske antigenreceptorer til modificerede t-celler
SG11201701565PA (en) * 2014-09-03 2017-03-30 Immunogen Inc Conjugates comprising cell-binding agents and cytotoxic agents
RS61010B1 (sr) * 2014-11-20 2020-11-30 Hoffmann La Roche Bispecifični antigen vezujući molekuli koji aktiviraju t ćelije protiv folr1 i cd3
WO2016126608A1 (en) * 2015-02-02 2016-08-11 Novartis Ag Car-expressing cells against multiple tumor antigens and uses thereof
CN122075735A (zh) * 2015-09-17 2026-05-26 伊缪诺金公司 包含抗folr1免疫缀合物的治疗组合
US10323038B2 (en) 2015-11-20 2019-06-18 Abide Therapeutics, Inc. Pyrazole compounds and methods of making and using same
US20190233512A1 (en) * 2016-10-12 2019-08-01 Sutro Biopharma, Inc. Anti-folate receptor antibodies, compositions comprising anti-folate receptor antibodies and methods of making and using anti-folate receptor antibodies
US10822410B2 (en) * 2016-11-23 2020-11-03 Eisai R&D Management Co., Ltd. Anti-folate receptor alpha antibodies and uses thereof

Similar Documents

Publication Publication Date Title
JP2022523710A5 (cg-RX-API-DMAC7.html)
US20240182542A1 (en) Multi-Specific Molecules
JP2021531826A5 (cg-RX-API-DMAC7.html)
CN110799539B (zh) 抗4-1bb抗体及其制备和使用方法
JP2022514693A5 (cg-RX-API-DMAC7.html)
KR102749049B1 (ko) 분자를 표적화하기 위한 항원 결합 구조체
JP7611931B2 (ja) ガイダンス及びナビゲーションコントロール(gnc)抗体様タンパク質、その製造方法及び使用方法
JP2013506428A5 (cg-RX-API-DMAC7.html)
CN110621337A (zh) 抗lag3人单克隆抗体及其用途
US20050142539A1 (en) Targeted ligands
JP2018532383A5 (cg-RX-API-DMAC7.html)
JP2020533004A5 (cg-RX-API-DMAC7.html)
JP2020534012A5 (cg-RX-API-DMAC7.html)
JP2019505564A5 (cg-RX-API-DMAC7.html)
JP2019512207A5 (cg-RX-API-DMAC7.html)
JP2019511212A5 (cg-RX-API-DMAC7.html)
JP2010511388A5 (cg-RX-API-DMAC7.html)
US12383631B2 (en) Immune antigen specific IL-18 immunocytokines and uses thereof
EP2486058A1 (en) Polypeptides for binding to the "receptor for advanced glycation endproducts" as well as compositions and methods involving the same
JP2022514786A5 (cg-RX-API-DMAC7.html)
EP3405494A1 (en) Ror2 antibody compositions and related methods
JP2025026839A5 (cg-RX-API-DMAC7.html)
CN108064247A (zh) 包含志贺毒素a亚基效应物区域的多价cd20结合分子及其富集组合物
JP2021512159A5 (cg-RX-API-DMAC7.html)
JP2022504826A5 (cg-RX-API-DMAC7.html)